GA
STJ

Geneva Advisors’s St Jude Medical STJ Stock Holding History

Geneva Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15,936
Closed -$1.28M – 844
2016
Q4 		$1.28M Buy
15,936
+96
+0.6% +$7.62K 0.02% 281
2016
Q3 		$1.26M Buy
15,840
+2,980
+23% +$241K 0.02% 273
2016
Q2 		$1M Buy
12,860
+8,060
+168% +$575K 0.02% 312
2016
Q1 		$264K Hold
4,800
– – 0.01% 565
2015
Q4 		$296K Hold
4,800
– – 0.01% 505
2015
Q3 		$303K Sell
4,800
-6,526
-58% -$466K 0.01% 480
2015
Q2 		$828K Buy
11,326
+5,006
+79% +$362K 0.01% 340
2015
Q1 		$413K Sell
6,320
-1,731
-22% -$115K 0.01% 450
2014
Q4 		$524K Hold
8,051
– – 0.01% 401
2014
Q3 		$484K Sell
8,051
-446
-5% -$29.1K 0.01% 425
2014
Q2 		$588K Buy
8,497
+3,220
+61% +$209K 0.01% 405
2014
Q1 		$345K Buy
5,277
+1,477
+39% +$96.1K 0.01% 453
2013
Q4 		$235K Sell
3,800
-600
-14% -$34.7K ﹤0.01% 439
2013
Q3 		$236K Hold
4,400
– – ﹤0.01% 433
2013
Q2 		$201K Buy
+4,400
New +$191K ﹤0.01% 393

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Geneva Advisors's STJ Position: Q1 2017 in Review

Geneva Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 15,936 shares — an estimated $1.28M sold.

Geneva Advisors first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $1.28M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Geneva Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Geneva Advisors sold 15,936 St Jude Medical shares in Q1 2017, an estimated $1.28M.
  • Geneva Advisors first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Geneva Advisors's St Jude Medical position peaked at $1.28M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Geneva Advisors's 13F filing for Q1 2017, filed 1 May 2017.